Yale Researchers Identify Tumor Reactive Immune Cells to Help Fight Against Advanced Melanoma
According to a new study led by Yale Cancer Center and Department of Neurology researchers, a simple blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma, a deadly form of skin cancer.
MD-PhD Student Eric Song Receives Prestigious Harold M. Weintraub Graduate Student Award
Eric Song, a fifth-year Yale School of Medicine (YSM) MD-PhD student, is one of the recipients of the 2021 Harold M. Weintraub Graduate Student Award, which recognizes outstanding achievement during graduate studies in the biological sciences. The awardees are selected based on the quality, originality, and scientific significance of their research, as well as to represent a diverse range of research topics.
Paving the Way for Cancer Health Equity
Since the appointment of Marcella Nunez-Smith, MD, MHS, as Director of the newly formed Center for Community Engagement and Health Equity (CEHE) within Smilow Cancer Hospital and Yale Cancer Center, the mission of ensuring cancer health equity and improving outcomes with an emphasis on traditionally marginalized communities, has begun to take shape.
Yale Neurologists Identify Consistent Neuroinflammatory Response in ICH Patients
According to a recent study published in "Science Immunology," A team of researchers from Yale and MIT partnernered with a large clinical trial of minimally-invasive surgery to tackle defining the human neuroinflammatory response in living patients suffering from intracerebral hemorrhage.
Yale-led Clinical Trial Offers Hope for COVID Patients and a Path Forward for Research
A new randomized study could reduce the morbidity and mortality associated with COVID-19 and streamline clinical research at Yale. The study will enroll 466 patients across five different Yale New Haven Hospital sites to identify a potential COVID-19 treatment.
Diverse Junior Scientists Display Their Talents and Learn to Navigate Academia
The fellows largely represented communities that have been historically unrepresented in the field of medical research, including those from ethnic and racial minorities, those with disabilities, those from low socioeconomic backgrounds, women, or those who identify as LGBTQI+.